Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
3.98
Dollar change
+0.35
Percentage change
9.49
%
Index- P/E- EPS (ttm)-3.11 Insider Own9.42% Shs Outstand20.74M Perf Week2.84%
Market Cap48.91M Forward P/E- EPS next Y-0.44 Insider Trans0.00% Shs Float11.13M Perf Month1.02%
Income-37.98M PEG- EPS next Q-0.49 Inst Own79.73% Short Float16.93% Perf Quarter53.08%
Sales0.00M P/S- EPS this Y53.22% Inst Trans-1.24% Short Ratio1.02 Perf Half Y56.69%
Book/sh-0.36 P/B- EPS next Y69.53% ROA-225.65% Short Interest1.88M Perf Year180.28%
Cash/sh0.78 P/C5.12 EPS next 5Y- ROE-536.81% 52W Range1.30 - 4.45 Perf YTD43.68%
Dividend Est.- P/FCF- EPS past 5Y43.13% ROI- 52W High-10.56% Beta0.92
Dividend TTM- Quick Ratio0.81 Sales past 5Y0.00% Gross Margin- 52W Low206.15% ATR (14)0.28
Dividend Ex-Date- Current Ratio0.81 EPS Y/Y TTM79.59% Oper. Margin0.00% RSI (14)55.96 Volatility8.00% 7.06%
Employees20 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.75
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q47.94% Payout- Rel Volume0.96 Prev Close3.63
Sales Surprise- EPS Surprise28.07% Sales Q/Q- EarningsMar 27 BMO Avg Volume1.84M Price3.98
SMA204.17% SMA508.07% SMA20052.07% Trades Volume1,760,676 Change9.49%
Date Action Analyst Rating Change Price Target Change
Jul-01-20Initiated Oppenheimer Outperform
Jan-21-20Resumed ROTH Capital Buy $10
Sep-13-19Initiated ROTH Capital Buy
Dec-21-16Initiated Ladenburg Thalmann Buy $2.70
Today 10:33AM
Mar-27-24 10:09PM
10:53AM
06:40AM
Mar-20-24 06:40AM
08:52AM Loading…
Mar-14-24 08:52AM
Mar-04-24 06:40AM
Feb-07-24 06:40AM
Jan-30-24 06:40AM
Jan-25-24 06:40AM
Jan-22-24 06:40AM
Jan-16-24 06:40AM
Jan-12-24 06:44AM
Jan-11-24 06:40AM
Jan-08-24 08:37AM
06:40AM Loading…
06:40AM
06:30AM
Jan-03-24 08:30AM
Dec-19-23 08:30AM
Dec-12-23 08:30AM
Dec-05-23 08:30AM
Nov-04-23 12:36PM
Nov-02-23 07:30AM
Oct-25-23 08:00AM
Oct-24-23 08:00AM
Oct-17-23 08:00AM
Oct-02-23 06:35AM
Sep-18-23 08:40AM
Sep-11-23 06:30AM
Sep-05-23 08:21AM
08:40AM Loading…
Aug-14-23 08:40AM
Jun-30-23 09:40AM
Jun-28-23 08:30AM
Jun-12-23 08:30AM
May-04-23 09:22AM
08:40AM
Mar-09-23 08:40AM
Mar-08-23 04:05PM
Feb-28-23 08:30AM
Feb-15-23 08:30AM
Nov-30-22 08:30AM
Nov-21-22 08:30AM
Nov-16-22 08:30AM
Nov-03-22 08:30AM
Oct-25-22 04:30PM
Oct-21-22 08:30AM
Sep-22-22 08:30AM
Sep-13-22 08:30AM
Aug-30-22 02:55PM
Aug-05-22 08:30AM
Jul-21-22 04:15PM
Jun-20-22 09:22AM
May-10-22 08:30AM
Apr-26-22 08:00AM
Apr-12-22 08:30AM
Mar-23-22 06:35PM
Mar-21-22 08:30AM
Mar-10-22 04:05PM
Feb-23-22 08:00AM
Jan-17-22 09:40AM
07:40AM
Jan-14-22 06:27AM
Jan-04-22 08:30AM
Dec-13-21 08:30AM
Dec-08-21 08:30AM
Nov-16-21 08:30AM
Nov-08-21 08:30AM
Nov-02-21 08:30AM
Oct-25-21 09:00AM
Sep-24-21 07:25AM
Sep-22-21 12:27PM
08:30AM
Sep-15-21 04:01PM
Sep-08-21 08:44AM
Sep-02-21 03:31PM
Aug-18-21 11:54AM
08:30AM
Aug-16-21 08:30AM
Aug-09-21 08:30AM
Jul-13-21 09:00AM
Jul-12-21 08:30AM
Jul-08-21 08:30AM
Jun-24-21 08:30AM
Jun-04-21 03:13PM
09:00AM
May-20-21 08:30AM
May-14-21 09:00AM
May-10-21 08:30AM
Apr-27-21 08:39AM
Mar-28-21 04:29AM
Mar-11-21 08:30AM
Mar-09-21 09:00AM
Mar-05-21 08:30AM
Mar-02-21 08:30AM
Feb-10-21 08:30AM
Jan-27-21 08:30AM
Jan-12-21 09:09AM
08:30AM
Dec-28-20 04:05PM
Dec-23-20 08:39AM
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124 which could detect tumors and metastases in a broad range of cancers and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.